Connect your AI

SLSN SLSN Contract Liabilities

Contract Liabilities at other companies

PTH

Pelthos Therapeutics Inc.PTHS

$1.03M—

Other financials

Income statement

Revenue$13.0M-11.4%

Gross profit$3.3M-1.3%

Operating income-$504.0K-297%

Net income-$766.0K-1,058%

EPS (diluted)-$0.01—

Balance sheet

Cash & equivalents$573.0K-68.5%

Total debt$9.7M-3.3%

Total equity$17.0M+11.9%

Total assets$47.8M-16.2%

Cash flow

Operating cash flow$1.5M+121%

CapEx$528.0K+497%

Free cash flow$989.0K+113%

Valuation

Market cap$51.91M-85.0%

Enterprise value$61.08M-82.5%

P/E55×—

P/S0.9×-4.5×

Profitability

Gross margin26.5%-1.5pp

Operating margin1.3%-6.5pp

Net margin1.6%—

FCF margin-20.1%—

Returns & leverage

Return on equity5.9%—

Debt / equity0.6×-0.1×

Current ratio2.1×+1.0×

Where this comes from

Reported directly by SLSN in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: SLSN’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SLSN's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is SLSN's contract liabilities?: SLSN (SLSN) reported contract liabilities of $1.17M in Q1 2026.
How has SLSN's contract liabilities changed year-over-year?: SLSN's contract liabilities decreased by 74.8% year-over-year, from $4.62M to $1.17M.
What is the long-term trend for SLSN's contract liabilities?: Over 5 years (2020 to 2025), SLSN's contract liabilities has grown at a 17.7% compound annual growth rate (CAGR), from $411K to $930K.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.